商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
METHOCARBAMOL | 209312 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | Yes | 2018/05/07 | 2018/05/07 | GRANULES | Prescription |
METHOCARBAMOL | 211504 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2018/10/26 | 2018/10/26 | GLAND PHARMA LTD | Prescription |
METHOCARBAMOL | 213967 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2020/08/12 | 2020/08/12 | AUROBINDO PHARMA LTD | Prescription |
METHOCARBAMOL | 213967 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2020/08/12 | 2023/02/09 | AUROBINDO PHARMA LTD | Prescription |
METHOCARBAMOL | 212623 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2021/04/30 | 2021/04/30 | ALLIED | Prescription |
METHOCARBAMOL | 212623 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2021/04/30 | 2021/04/30 | ALLIED | Prescription |
METHOCARBAMOL | 215065 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2022/07/14 | 2022/07/14 | BAXTER HLTHCARE CORP | Discontinued |
METHOCARBAMOL | 212707 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 1GM | No | No | 2023/06/12 | 2023/06/12 | MIKART | Prescription |